How robust are the natural history parameters used in chlamydia transmission dynamic models? A systematic review

Theoretical Biology and Medical Modelling

Volumn 11, Issue 1, 2014, Pages

  Davies, Bethan ^a   Anderson, Sarah Jane ^a   Turner, Katy M E ^b   Ward, Helen ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Chlamydia trachomatis; Mathematical modelling; Natural history; Screening; Systematic review

Indexed keywords

CHLAMYDIASIS; DISEASE TRANSMISSION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MALE; PROBABILITY; REVIEW; THEORETICAL MODEL;

CHLAMYDIA INFECTIONS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MODELS, THEORETICAL; PROBABILITY;

EID: 84893185927     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-11-8     Document Type: Review

References (60)

1. National Chlamydia screening programme. NCSP, 2013 [cited 2013 07/06/2013]; Available from: http://www.chlamydiascreening.nhs.uk/ps/
2. ECDC. ECDC Guidance, Chlamydia Control in Europe Stockholm: European Centre for Disease Prevention and Control 2009 2009
3. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? Gottlieb SL, Berman SM, Low N, J Infect Dis 2010 201 Suppl 2 156 S167 20470051
4. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Kretzschmar M, et al. Am J Epidemiol 2001 153 1 90 101 10.1093/aje/153.1.90 11159151 (Pubitemid 32042160)
5. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Low N, et al. Health Technol Assess 2007 11 8 ii iv ix-xii, 1-165
6. Costs and effects of chlamydial screening: dynamic versus static modeling. Welte R, et al. Sex Transm Dis 2005 32 8 474 483 10.1097/01.olq. 0000161181.48687.cf 16041248 (Pubitemid 41060386)
7. Anderson RM, RM, Infectious Diseases of Humans: Dynamics and Control Oxford, UK: Oxford University Press 1991
8. Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data. Althaus CL, et al. J R Soc Interface 2012 9 66 136 146 10.1098/rsif.2011.0131 21653569
9. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. Geisler WM, J Infect Dis 2010 201 Suppl 2 104 S113 20470048
10. Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study. Kretzschmar M, et al. Sex Transm Infect 2009 85 5 359 366 10.1136/sti.2009.036251 19454407
11. Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. Althaus CL, et al. Epidemics 2010 2 3 123 131 10.1016/j.epidem.2010.04.002 21352783
12. Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling. Roberts TE, et al. Sex Transm Infect 2006 82 3 193 200 discussion 201 10.1136/sti.2005.017517 16731666 (Pubitemid 43901584)
13. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies. Herzog SA, et al. Sex Transm Dis 2012 39 8 628 637 10.1097/OLQ.0b013e31825159ff 22801346
14. The cost effectiveness of opportunistic chlamydia screening in England. Adams EJ, Turner KM, Edmunds WJ, Sex Transm Infect 2007 83 4 267 274 discussion 274-5 10.1136/sti.2006.024364 17475686
15. Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis infections. Andersen B, et al. Sex Transm Dis 2006 33 7 407 415 10.1097/01.olq.0000200609.77577.3f 16601656 (Pubitemid 43964749)
16. Cost-utility of repeated screening for chlamydia trachomatis. de Vries R, et al. Value Health 2008 11 2 272 274 10.1111/j.1524-4733.2007.00225.x 18380639 (Pubitemid 351473602)
17. Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data. de Vries R, et al. Value Health 2006 9 1 1 11 10.1111/j.1524-4733.2006.00075.x 16441519
18. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland. Gillespie P, et al. Sex Transm Infect 2012 88 3 222 228 10.1136/sextrans-2011-050067 22213681
19. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project. Roberts TE, et al. Br Med J 2007 335 7614 291 294A 10.1136/bmj.39262.683345.AE (Pubitemid 47280805)
20. Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada. Tuite AR, et al. Sex Transm Dis 2012 39 4 260 267 10.1097/OLQ.0b013e31824717ae 22421691
21. Analysing the effectiveness of Chlamydia screening. Townshend JRP, Turner HS, J Oper Res Soc 2000 51 7 812 824
22. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Welte R, et al. Sex Transm Dis 2000 27 9 518 529 10.1097/00007435-200010000-00005 11034526
23. The Philadelphia high-school STD screening program: key insights from dynamic transmission modeling. Fisman DN, et al. Sex Transm Dis 2008 35 11 61 S65 doi:10.1097/OLQ.0b013e3181802822 18607306
24. Developing a realistic sexual network model of chlamydia transmission in Britain. Turner KM, et al. Theor Biol Med Model 2006 3 3 10.1186/1742-4682-3-3 16426453
25. Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV. Golden MR, et al. Sex Transm Dis 2003 30 6 490 496 10.1097/00007435-200306000-00004 12782949 (Pubitemid 36667028)
26. Estimating Chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States. Tao G, Tian LH, Peterman TA, Sex Transm Dis 2007 34 3 180 182 10.1097/01.olq.0000230437.79119.31 16865052 (Pubitemid 46673223)
27. Untreated gonococcal and chlamydial infection in a probability sample of adults. Turner CF, et al. JAMA 2002 287 6 726 733 10.1001/jama.287.6.726 11851539 (Pubitemid 34250458)
28. Genital chlamydial infections: epidemiology and reproductive sequelae. Cates W Jr, Wasserheit JN, Am J Obstet Gynecol 1991 164 6 Pt 2 1771 1781 2039031
29. New opportunities for Chlamydia prevention-applications of science to public-health practice. Hillis S, et al. Sex Transm Dis 1995 22 3 197 202 10.1097/00007435-199505000-00011 7652664
30. Chlamydia-trachomatis infections. Hossain A, Int J Gynecol Obstet 1989 29 2 107 115 10.1016/0020-7292(89)90838-2 (Pubitemid 19196946)
31. Ubiquitous parasites: Chlamydial infections now commonest sex-transmitted disease. Maurice J, Int Health Mag 1983 3 19
32. Control of Chlamydia: a role for every clinician who sees sexually active patients. Schachter JM, Sweet RL, et al. J Clin Out Manag 1997 4 60 73
33. Asymptomatic carriage of Chlamydia-trachomatis-a study of 109 teenage girls. Rahm VA, et al. EurJ Sex Transm Dis 1986 3 2 91 94 (Pubitemid 16157794)
34. Epidemiologic differences between chlamydia and gonorrhea. Zimmerman HL, et al. Am J Public Health 1990 80 11 1338 1342 10.2105/AJPH.80.11.1338 2240301 (Pubitemid 20375551)
35. Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Adams EJ, et al. Sex Transm Infect 2004 80 5 354 362 10.1136/sti.2003.005454 15459402 (Pubitemid 39389552)
36. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Johnson AM, et al. Lancet 2001 358 9296 1835 1842 10.1016/S0140-6736(01)06883-0 11741621 (Pubitemid 34008648)
37. An economic-evaluation of screening for Chlamydia-trachomatis in adolescent males. Genc M, Ruusuvaara L, Mardh PA, JAMA 1993 270 17 2057 2064 10.1001/jama.1993.03510170047029 8411572 (Pubitemid 23318169)
38. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women-implications for a national Chlamydia control strategy. Marrazzo JM, et al. Sex Transm Dis 1997 24 3 131 141 10.1097/00007435-199703000-00003 9132979 (Pubitemid 27123188)
39. Patient referral outcome in gonorrhoea and chlamydial infections. van Duynhoven YTHP, et al. Sex Transm Infect 1998 74 5 323 330 10.1136/sti.74.5.323 10195026 (Pubitemid 28467320)
40. Partner referral by patients with gonorrhea and chlamydial infection-case-finding observations. van de Laar MJW, Termorshuizen F, VandenHoek A, Sex Transm Dis 1997 24 6 334 342 10.1097/00007435-199707000-00005 9243740 (Pubitemid 27306582)
41. Contact Tracing in Genital Chlamdial Infection. Thelin I, M.P.-A, Chlamydia Trachomatis in Genital and Related Infections Stockholm, Sweden: Almqvist & Wiksell International, M.B. Mardh P-A, Paavonen J, 1982 163 166 (Pubitemid 12033640)
42. Chlamydial and gonococcal infections in a defined population of women. Westrom L, et al. Scand J Infect Dis Suppl 1982 32 157 162 6958012 (Pubitemid 12033639)
43. Asymptomatic teenage girls should be tested for chlamydial infection. Edgardh K, Bygdeman S, Sandstrom E, Backman M, Lakartidningen 1987 84 1854 1847
44. Chlamydia Trachomatis Infections of the Adult. Stamm WE, Holmes KK, Sexually Transmitted Diseases USA: McGraw-Hill, Holmes KK, 1990 181 194
45. Toward control of sexually transmitted chlamydial infections. Stamm WE, Ann Intern Med 1993 119 5 432 434 10.7326/0003-4819-119-5-199309010-00017 8338302 (Pubitemid 23310096)
46. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis. Harrison HR, et al. Am J Obstet Gynecol 1985 153 3 244 251 10.1016/S0002-9378(85)80105-8 4050890 (Pubitemid 15241074)
47. Screening for chlamydial infection is women attending family planning clinics. Schachter J, S.E, Moncada J, West J Med 1983 138 375 379 6858125
48. Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. Kretzschmar M, Van Duynhoven Y, Severijnen AJ, Am J Epidemiol 1996 144 3 306 317 10.1093/oxfordjournals.aje.a008926 8686700 (Pubitemid 26313508)
49. Asymptomatic Chlamydia trachomatis urethritis in men. Stamm WE, Cole B, Sex Transm Dis 1986 13 3 163 165 10.1097/00007435-198607000-00010 3764626 (Pubitemid 17107545)
50. Duration of untreated genital infections with chlamydia trachomatis: a review of the literature. Golden MR, et al. Sex Transm Dis 2000 27 6 329 337 10.1097/00007435-200007000-00006 10907908 (Pubitemid 30439547)
51. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Korenromp EL, et al. Int J STD AIDS 2002 13 2 91 101 10.1258/0956462021924712 11839163 (Pubitemid 34135474)
52. Cost-Effectiveness of Testing for Chlamydial Infections in Asymptomatic Women. Buhaug H, et al. Med Care 1989 27 8 833 841 10.1097/00005650-198908000- 00007 2502694
53. van de Laar MJW, Seksueel Overdraagbare Aandoeningen In Nederland Bilthoven: Rijksinstituut Voor Volksgezondheid En Milieuhygiene 1993
54. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Buhaug H, et al. Br J Gen Pract 1990 40 333 142 145 2115349
55. Estimating transmission probabilities for chlamydial infection. Katz B, Statist Med 1992 11 565 577 10.1002/sim.4780110502
56. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. Quinn TC, et al. JAMA 1996 276 21 1737 1742 10.1001/jama.1996.03540210045032 8940322 (Pubitemid 26423966)
57. Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force working group-5. Pitman R, et al. Med Decis Making 2012 32 5 712 721 10.1177/0272989X12454578 22990086
58. Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs. Brisson M, Edmunds WJ, Med Decis Making 2006 26 5 434 446 10.1177/0272989X06290485 16997923 (Pubitemid 44410295)
59. Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection. Price MJ, et al. Stat Med 2013 32 9 1547 1560 10.1002/sim.5603 22949217
60. Towards more robust estimates of the transmissibility of Chlamydia trachomatis. Althaus CL, Heijne JC, Low N, Sex Transm Dis 2012 39 5 402 404 10.1097/OLQ.0b013e318248a550 22504608